David Konys

Title: David Konys: Innovator in RNA Interference Technology

Introduction

David Konys is a notable inventor based in Natick, MA (US). He has made significant contributions to the field of RNA interference (RNAi) technology. His innovative work focuses on developing new methods for delivering oligonucleotides effectively to target tissues.

Latest Patents

David Konys holds a patent for "Compositions and methods for mediating RNAi in vivo." This invention relates to new formulated lipid particles (FLiPs) that comprise at least one single or double-stranded oligonucleotide. The oligonucleotide is conjugated to a lipophile and associated with an emulsion or liposome. These lipid particles have been shown to effectively deliver oligonucleotides to the heart, lung, and muscle, where they can mediate gene silencing.

Career Highlights

Throughout his career, David has worked with prominent organizations, including Alnylam Pharmaceuticals, Inc. and ETH Zurich. His experience in these companies has allowed him to advance his research and contribute to the development of innovative therapeutic solutions.

Collaborations

David has collaborated with notable professionals in his field, including Akin Akinc and Tomoko Nakayama. These partnerships have further enriched his work and expanded the impact of his inventions.

Conclusion

David Konys is a pioneering inventor whose work in RNA interference technology has the potential to revolutionize gene therapy. His innovative approaches and collaborations continue to drive advancements in the field.